Note: Ingredients listed on restricted chemical lists
EC/CAS
9005-25-8
Name of the chemical
Starch
Concentration
>=50-<70
EC/CAS
557-04-0
Name of the chemical
Aluminium, zinc, magnesium and calcium stearates
Concentration
>=1-<5
EC/CAS
7631-86-9
Name of the chemical
Silver adsorbed on silicon dioxide
Concentration
>=1-<5
General Information
Version
2.0
Revision date
2022-03-16
Product name
SIFROL, CRTAB/ 30/1.5MG CSA RA/RCH/PE/PY
Product Synonyms
Sifrol® 0.088 mg tablets, Sifrol® 0.18 mg tablets, Sifrol® 0.35 mg tablets, Sifrol® 0.7 mg tablets, Sifrol® 1.1 mg tablets, Sifrol® 0.26 mg extended release tablets, Sifrol® 0.52 mg extended release tablets, Sifrol® 1.05 mg extended release tablets, Sifrol® 1.57 mg extended release tablets, Sifrol® 2.1 mg extended release tablets, Sifrol® 2.62 mg extended re- lease tablets, Sifrol® 3.15 mg extended release tablets with API: Pramipexol dihydrochloride monohydrate
1.2.1 Relevant identified uses
Pharmaceutical
1.2.2. Uses advised against
Safety Data Sheet only for the professional user
supplier name
Boehringer Ing. Pharma GmbH & Co. KG
Emergency telephone
+1 703-527-3887, +49800 1817059
Icons in SDS
Company Information
company name
Boehringer Ing. Pharma GmbH & Co. KG
e-mail address of the competent person responsible for the Safety Data Sheet
EHS-Services@Boehringer-Ingelheim.com
Section 2
SECTION 2: Hazards identification
OSHA Hazards GHS classification in accordance with the
2.2 Label elements
Not a hazardous substance or mixture.
2.3 Other hazards
The pharmacological effect of the medicament has to be considered (see package leaflet). This drug is not subject to the labelling requirements under the Globally Harmonized System (GHS)